Veno-occlusive disease/sinusoidal obstruction syndrome in patients with prior gemtuzumab ozogamicin: literature analysis of survival after defibrotide treatment

por Richardson, Paul G., Corbacioglu, Selim
Publicado 2020

Revised international staging system allocation in the ICARIA‐MM study: Practical challenges and impact on outcome

por Richardson, Paul G., Perrot, Aurore, Takamatsu, Hiroyuki
Publicado 2021

Optimizing therapy for del(17p) multiple myeloma

por Avet-Loiseau, Hervé, Richardson, Paul G., di Bacco, Alessandra
Publicado 2017

A review of lenalidomide in combination with dexamethasone for the treatment of multiple myeloma

por Hideshima, Teru, Raje, Noopur, Richardson, Paul G, Anderson, Kenneth C
Publicado 2008

Pulmonary and Hepatic Complications of Hematopoietic Cell Transplantation

por Yanik, Gregory A., Cooke, Kenneth R., Ho, Vincent T., Richardson, Paul G.
Publicado 2013

A clinical perspective on plasma cell leukemia; current status and future directions

por Tuazon, Sherilyn A., Holmberg, Leona A., Nadeem, Omar, Richardson, Paul G.
Publicado 2021

Controversy in the Use of CD38 Antibody for Treatment of Myeloma: Is High CD38 Expression Good or Bad?

por Plesner, Torben, van de Donk, Niels W. C. J., Richardson, Paul G.
Publicado 2020

Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review

por McCaughan, Georgia J., Gandolfi, Sara, Moore, John J., Richardson, Paul G.
Publicado 2022

Incidence of Anicteric Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome and Outcomes with Defibrotide following Hematopoietic Cell Transplantation in Adult and Pediatric Pati...

por Corbacioglu, Selim, Kernan, Nancy A., Pagliuca, Antonio, Ryan, Robert J., Tappe, William, Richardson, Paul G.
Publicado 2020

The importance of endothelial protection: the emerging role of defibrotide in reversing endothelial injury and its sequelae

por Richardson, Paul G., Palomo, Marta, Kernan, Nancy A., Hildebrandt, Gerhard C., Chao, Nelson, Carreras, Enric
Publicado 2021

Analysis of Time to Complete Response after Defibrotide Initiation in Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transpla...

por Richardson, Paul G., Smith, Angela R., Kernan, Nancy A., Lehmann, Leslie, Ryan, Robert J., Grupp, Stephan A.
Publicado 2020

KDM6B modulates MAPK pathway mediating multiple myeloma cell growth and survival

por Ohguchi, Hiroto, Harada, Takeshi, Sagawa, Morihiko, Kikuchi, Shohei, Tai, Yu-Tzu, Richardson, Paul G., Hideshima, Teru, Anderson, Kenneth C.
Publicado 2017

Meaningful changes in end-of-life care among patients with myeloma

por Odejide, Oreofe O., Li, Ling, Cronin, Angel M., Murillo, Anays, Richardson, Paul G., Anderson, Kenneth C., Abel, Gregory A.
Publicado 2018

Dose and Schedule Selection of the Oral Proteasome Inhibitor Ixazomib in Relapsed/Refractory Multiple Myeloma: Clinical and Model-Based Analyses

por Gupta, Neeraj, Yang, Huyuan, Hanley, Michael J., Zhang, Steven, Liu, Rachael, Kumar, Shaji, Richardson, Paul G., Skacel, Tomas, Venkatakrishnan, Karthik
Publicado 2017

Endothelial dysfunction and its critical role in COVID‐19‐associated coagulopathy: Defibrotide as an endothelium‐protective, targeted therapy

por García‐Bernal, David, Richardson, Edward, Vlodavsky, Israel, Carlo‐Stella, Carmelo, Iacobelli, Massimo, Jara, Rubén, Richardson, Paul G., Moraleda, Jose M.
Publicado 2021

Advances in the treatment of monoclonal gammopaties: The emerging role of targeted therapy in plasma cell dyscrasias

por Roccaro, Aldo M, Ghobrial, Irene M, Blotta, Simona, Treon, Steven P, Malagola, Michele, Anderson, Kenneth C, Richardson, Paul G, Russo, Domenico
Publicado 2008

New developments in the management of relapsed/refractory multiple myeloma – the role of ixazomib

por Richardson, Paul G, Kumar, Shaji, Laubach, Jacob P, Paba-Prada, Claudia, Gupta, Neeraj, Berg, Deborah, van de Velde, Helgi, Moreau, Philippe
Publicado 2017

Pooled analysis of Day 100 survival for defibrotide‐treated patients with hepatic veno‐occlusive disease/sinusoidal obstruction syndrome and ventilator or dialysis dependence follo...

por Richardson, Paul G., Smith, Angela R., Kernan, Nancy A., Lehmann, Leslie, Soiffer, Robert J., Ryan, Robert J., Tappe, William, Grupp, Stephan
Publicado 2020

Predictive biomarkers with isatuximab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma

por Richardson, Paul G., Facon, Thierry, Bensinger, William I., Leleu, Xavier, Campana, Frank, Macé, Sandrine, Chiron, Marielle, van de Velde, Helgi, Mikhael, Joseph
Publicado 2021

An overview of treatment options for patients with relapsed/refractory multiple myeloma and renal impairment

por Dimopoulos, Meletios A., Mikhael, Joseph, Terpos, Evangelos, Leleu, Xavier, Moreau, Philippe, Bladé, Joan, Kim, Jin Seok, Stockerl-Goldstein, Keith, Richardson, Paul G.
Publicado 2022